Long-term Evaluation of Teeth and Implants During the Periodic Maintenance in Patients with Viral Liver Disease

Overview

Journal J Adv Prosthodont

Specialty Dentistry

Date 2016 Aug 25

PMID 27555902

Citations 2

Authors

Da-Le Yoon

Yong-Gun Kim

Jin-Hyun Cho

Sang-Kyu Lee

Jae-Mok Lee

Affiliations

Soon will be listed here.

Abstract

Purpose: This study was designed to investigate the maintenance of teeth and implants in patients with viral liver disease.

Materials And Methods: 316 patients without any significant systemic disease were selected as a control group. Liver disease group was consisted of 230 patients. Necessary data were collected using clinical records and panoramic radiographs. Then, the patients were subdivided into 2 groups based on the type of active dental therapy received before maintenance period (Pre-Tx). Analysis for finding statistically significant difference was performed based on the need for re-treatment of active dental therapy (Re-Tx) and change in the number of teeth (N-teeth) and implants (N-implants).

Results: Comparing to control group, the patients with liver disease showed higher value on N-teeth, N-implants, and Re-Tx. Statistically significant differences were found on N-teeth (P=.000) and Re-Tx (P=.000) in patients with non-surgical Pre-Tx. Analysis based on severity of liver disease showed that N-teeth and Re-Tx were directly related to severity of liver disease regardless of received type of Pre-Tx. Significant differences were found on N-teeth (P=.003) and Re-Tx (P=.044) in patients with non-surgical Pre-Tx.

Conclusion: In this study, it was concluded that liver disease might influence the loss of teeth and cause the relapse of dental disease during maintenance period in patients. A significant positive relationship between tooth and implant loss and severity of liver disease seems to exist.

Citing Articles

Bone healing around titanium implants in a preclinical model of bile duct ligation-induced liver injury.

Talebian R, Kampleitner C, Sagl B, Kuchler U, Dehpour A, Gruber R Clin Oral Implants Res. 2021; 32(8):980-988.

PMID: 34114694 PMC: 8453542. DOI: 10.1111/clr.13792.

3-dimensional analysis about the effects of aging and risk factors on changes in oral environment.

Yoon Y, Kim Y, Lee S, Lee J J Adv Prosthodont. 2019; 11(2):75-80.

PMID: 31080567 PMC: 6491359. DOI: 10.4047/jap.2019.11.2.75.

References

Grossmann S, Teixeira R, de Aguiar M, de Moura M, Vieira do Carmo M . Oral mucosal conditions in chronic hepatitis C Brazilian patients: a cross-sectional study. J Public Health Dent. 2009; 69(3):168-75. DOI: 10.1111/j.1752-7325.2009.00119.x. View

Agha-Hosseini F, Mahboobi N, Safari S, Lavanchy D, Alavian S . Hepatitis B virus infection in dentistry: a forgotten topic. J Viral Hepat. 2010; 17(5):307-16. DOI: 10.1111/j.1365-2893.2010.01284.x. View

DePaola L . Managing the care of patients infected with bloodborne diseases. J Am Dent Assoc. 2003; 134(3):350-8. DOI: 10.14219/jada.archive.2003.0166. View

Coates E, Brennan D, Logan R, Goss A, Scopacasa B, Spencer A . Hepatitis C infection and associated oral health problems. Aust Dent J. 2000; 45(2):108-14. DOI: 10.1111/j.1834-7819.2000.tb00249.x. View

Golla K, Epstein J, Cabay R . Liver disease: current perspectives on medical and dental management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 98(5):516-21. DOI: 10.1016/S1079210404006432. View

Liu J . Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver. World J Gastroenterol. 2014; 20(40):14672-85. PMC: 4209533. DOI: 10.3748/wjg.v20.i40.14672. View

Douglas L, Douglass J, Sieck J, Smith P . Oral management of the patient with end-stage liver disease and the liver transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86(1):55-64. DOI: 10.1016/s1079-2104(98)90150-0. View

Lockhart P, Gibson J, Pond S, Leitch J . Dental management considerations for the patient with an acquired coagulopathy. Part 1: Coagulopathies from systemic disease. Br Dent J. 2003; 195(8):439-45. DOI: 10.1038/sj.bdj.4810593. View

Ng M, Ong M, Lim L, Koh C, Chan Y . Tooth loss in compliant and non-compliant periodontally treated patients: 7 years after active periodontal therapy. J Clin Periodontol. 2011; 38(5):499-508. DOI: 10.1111/j.1600-051X.2011.01708.x. View

10.

Radcke S, Dillon J, Murray A . A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes. Eur J Gastroenterol Hepatol. 2014; 27(1):1-7. DOI: 10.1097/MEG.0000000000000233. View

11.

Bagan J, Alapont L, Sanz C, del Olmo J, Morcillo E, Cortijo J . [Dental and salivary alterations in patients with liver cirrhosis: a study of 100 cases]. Med Clin (Barc). 1998; 111(4):125-8. View

12.

Novacek G, Plachetzky U, Potzi R, Lentner S, Slavicek R, Gangl A . Dental and periodontal disease in patients with cirrhosis--role of etiology of liver disease. J Hepatol. 1995; 22(5):576-82. DOI: 10.1016/0168-8278(95)80453-6. View

13.

Demas P, McClain J . Hepatitis: implications for dental care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88(1):2-4. DOI: 10.1016/s1079-2104(99)70184-8. View

14.

Konig J, Plagmann H, Ruhling A, Kocher T . Tooth loss and pocket probing depths in compliant periodontally treated patients: a retrospective analysis. J Clin Periodontol. 2002; 29(12):1092-100. DOI: 10.1034/j.1600-051x.2002.291208.x. View

15.

Guggenheimer J, Eghtesad B, Close J, Shay C, Fung J . Dental health status of liver transplant candidates. Liver Transpl. 2007; 13(2):280-6. DOI: 10.1002/lt.21038. View

16.

Grau-Garcia-Moreno D . [Dental management of patients with liver disease]. Med Oral. 2003; 8(3):231. View

17.

Wisnom C, Siegel M . Advances in the diagnosis and management of human viral hepatitis. Dent Clin North Am. 2003; 47(3):431-47. DOI: 10.1016/s0011-8532(03)00021-1. View

18.

Ilguy D, Ilguy M, Dincer S, Bayirli G . Prevalence of the patients with history of hepatitis in a dental facility. Med Oral Patol Oral Cir Bucal. 2006; 11(1):E29-32. View